Research shows bimagrumab may prevent muscle and bone loss associated with weight loss medications like Wegovy, offering hope ...
Two of Bambusa’s bispecific antibody candidates for immunological and inflammatory disorders are set to enter the clinic in ...
An investigational therapy significantly shrank lung cancer tumors that are notoriously resistant to treatment by encouraging ...
Scientists have discovered an antibody treatment that may help prevent both muscle loss and bone density loss in people using GLP-1 drugs such as Ozempic and Wegovy after losing weight.
1d
News Medical on MSNHarbour BioMed partners with Insilico to accelerate AI-powered antibody discoveryHarbour BioMed (HKEX: 02142, the "Company"), a global biopharmaceutical company committed to the discovery, development and commercialization of novel antibody therapeutics focusing on immunology and ...
February 20, 2025, Harbour BioMed (HKEX: 02142, the "Company"), a global biopharmaceutical company committed to the discovery ...
From preclinical research to regulatory approval and clinical adoption, diagnostic testing underpins every stage of ADC ...
Alloy Therapeutics Inc. (“Alloy”), a biotechnology ecosystem company dedicated to democratizing access to cutting edge drug ...
A study published in December by Duke professor Rohit Singh and his team proposes a new computational model called antibody ...
New Hampshire’s Bio X Cell, which has made a name for itself over the past quarter-century cranking out functional antibodies ...
Anti-acetylcholine receptor antibody (AChR-Ab) titers and the AChR-Ab rates of change correlated with myasthenia gravis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results